Deliver Your News to the World

CybeRelease: TheCapitalReport.com Issues (OTC: HYPF) Investor Alert


WEBWIRE

(CybeRelease, December 12, 2006) - LAKE HARMONY, PA - TheCapitalReport.com issues an investor alert on HyPower Fuel, Inc. (OTC PK: HYPF) after the Company announced that it has retained the services of renown patent attorney, Mr. Robert Shaver of Dykas Shaver & Nipper, LLP to commence work on a process patent for its newly developed high-efficiency electrolyzer.

The H2 Reactor is an electrolyzer that uses a unique process of electrolysis to create hydrogen and oxygen gases from water. After extensive technical research and development work with its joint venture partner, HyPower believes that the H2 Reactor’s electrolysis process is technologically the most efficient to date with an unprecedented ratio of 1 liter of hydrogen production to an electrical input of 1 watt hour.

This is approximately 2 to 2.5 times more efficient than the current state of the competing technology.
Please visit http://www.TheCapitalReport.com for an HYPF profile and other “Stocks to Watch.”

TheCapitalReport.com is an online financial destination where money managers, analysts, and individual investors can converge to discover new and exciting investment news, opportunities, and ideas. TheCapitalReport.com is focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street.

CybeRelease Gainers are Palomar Medical Technologies, Inc. (Nasdaq: PMTI), First Niagara Financial Group Inc. (Nasdaq: FNFG), Energy Conversion Devices, Inc. (Nasdaq: ENER), EFJ Inc. (Nasdaq: EFJI), Hayes Lemmerz International, Inc. (Nasdaq: HAYZ), Taro Pharmaceutical Industries Ltd. (Nasdaq: TARO), Global Sources Ltd. (Nasdaq: GSOL) and Ness Technologies, Inc. (Nasdaq: NSTC).

CybeRelease Decliners are NeoPharm, Inc. (Nasdaq: NEOL), AtheroGenics, Inc. (Nasdaq: AGIX), Leadis Technology, Inc. (Nasdaq: LDIS), Northfield Laboratories Inc. (Nasdaq: NFLD), Diodes Incorporated (Nasdaq: DIOD), Cutera, Inc. (Nasdaq: CUTR), Immunomedics, Inc. (Nasdaq: IMMU), and En Pointe Technologies, Inc. (Nasdaq: ENPT).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $995.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.



WebWireID24948





This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.